Page last updated: 2024-10-26

domperidone and Arrhythmias, Cardiac

domperidone has been researched along with Arrhythmias, Cardiac in 36 studies

Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.

Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.

Research Excerpts

ExcerptRelevanceReference
"We systematically searched MEDLINE, PubMed, EMBASE, Scopus and CINAHL Plus to identify observational studies examining the association of domperidone and sudden cardiac death and/or ventricular arrhythmia."9.12Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies. ( Douros, A; Filion, KB; Moriello, C; Ou, LB, 2021)
"The first author performed EMBASE, PubMed and Scopus searches to identify human studies assessing the association between current domperidone exposure and cardiac arrhythmia or sudden death."8.93Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis. ( Holcombe, A; Leelakanok, N; Schweizer, ML, 2016)
" This study aimed to examine the risk of severe domperidone-induced ventricular arrhythmia (VA), compared to mosapride, itopride, or non-use of all three prokinetics, in the general population."7.96Risk of domperidone induced severe ventricular arrhythmia. ( Kim, K; Lee, H; Lee, YC; Min, YW; Rhee, PL; Son, HJ; Song, BG, 2020)
"The aim of this study is to examine the relationship between domperidone (commonly used off-label for lactation stimulation), ventricular arrhythmia and all-cause mortality during the postpartum period."7.83The association between domperidone and ventricular arrhythmia in the postpartum period. ( Hanley, GE; Mintzes, B; Morgan, SG; Oberlander, TF; Smolina, K, 2016)
"The results of two large epidemiological studies on the association between domperidone and ventricular arrhythmia or sudden cardiac death were published in 2015; one study was conducted in Taiwan and the other in the United Kingdom."7.83Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia. ( , 2016)
"Recent evidence suggested that oral form of domperidone may possess pro-arrhythmic effects and increase the risk of ventricular arrhythmia."7.81Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study. ( Chen, HL; Hsiao, FY, 2015)
"Domperidone, a "hidden" neuroleptic, is used for symptomatic treatment of gastroesophageal reflux disease, despite its uncertain efficacy."7.78Domperidone: ventricular arrhythmia and sudden death (continued). ( , 2012)
"Domperidone is a prokinetic agent widely prescribed in adults and children with gastrointestinal disorders."6.46Domperidone and long QT syndrome. ( Giorgi, G; Rossi, M, 2010)
"Severe cardiac arrhythmias occurred in two patients."5.27Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidone. ( Hamer, J; Hunter, RW; Osborne, RJ; Slevin, ML, 1985)
"We systematically searched MEDLINE, PubMed, EMBASE, Scopus and CINAHL Plus to identify observational studies examining the association of domperidone and sudden cardiac death and/or ventricular arrhythmia."5.12Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies. ( Douros, A; Filion, KB; Moriello, C; Ou, LB, 2021)
" From these publications, it cannot be concluded that domperidone exposure definitely increases the risk of "sudden cardiac death", "death associated with ventricular arrhythmia" or "ventricular arrhythmia" The most concrete result of these studies is that the risk is higher with metoclopramide exposure compared to domperidone exposure."5.01Critical review of European Medicines Agency (EMA) assessment report and related literature on domperidone. ( Tuğlular, I; Yüksel, K, 2019)
"The first author performed EMBASE, PubMed and Scopus searches to identify human studies assessing the association between current domperidone exposure and cardiac arrhythmia or sudden death."4.93Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis. ( Holcombe, A; Leelakanok, N; Schweizer, ML, 2016)
"To evaluate the risk of QT prolongation, ventricular arrhythmias and sudden cardiac death associated with the use of oral domperidone in adults without cancer."4.91[Cardiac adverse effects of domperidone in adult patients: a systematic review]. ( Avila, A; Caraballo, L; Marzi, M; Molina, G; Piskulic, L; Weitz, D, 2015)
" Reports of QT prolongation, ventricular arrhythmias and SCD were located (predominantly high/very high-dose IV domperidone)."4.91Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations. ( Buffery, PJ; Strother, RM, 2015)
" This study aimed to examine the risk of severe domperidone-induced ventricular arrhythmia (VA), compared to mosapride, itopride, or non-use of all three prokinetics, in the general population."3.96Risk of domperidone induced severe ventricular arrhythmia. ( Kim, K; Lee, H; Lee, YC; Min, YW; Rhee, PL; Son, HJ; Song, BG, 2020)
"Risk-minimization measures (RMM), including label revisions were implemented in Europe for domperidone because of evidence of increased incidence of cardiac arrhythmia and sudden cardiac death."3.91Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe. ( Fife, D; Hu, P; Kaplan, S; Oliveria, SA; Phillips, S; Richarz, U; Waller, J, 2019)
"Observational retrospective studies have linked domperidone and prolonged QT interval, ventricular arrhythmias and risk of sudden death."3.85[Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database]. ( Auffret, M; Béné, J; Gautier, S; Rochoy, M, 2017)
"The aim of this study is to examine the relationship between domperidone (commonly used off-label for lactation stimulation), ventricular arrhythmia and all-cause mortality during the postpartum period."3.83The association between domperidone and ventricular arrhythmia in the postpartum period. ( Hanley, GE; Mintzes, B; Morgan, SG; Oberlander, TF; Smolina, K, 2016)
"The results of two large epidemiological studies on the association between domperidone and ventricular arrhythmia or sudden cardiac death were published in 2015; one study was conducted in Taiwan and the other in the United Kingdom."3.83Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia. ( , 2016)
" In 2012, Health Canada released a warning regarding domperidone use, based on associations with life-threatening arrhythmias and death."3.83Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a "Black Box" Warning: A Canadian Tertiary Care Center Study. ( Al-Dabbagh, R; Cooray, M; Forbes, N; Liu, LW; Tse, F; Xenodemetropoulos, T; Yuan, Y, 2016)
"Recent evidence suggested that oral form of domperidone may possess pro-arrhythmic effects and increase the risk of ventricular arrhythmia."3.81Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study. ( Chen, HL; Hsiao, FY, 2015)
"Domperidone, a "hidden" neuroleptic, is used for symptomatic treatment of gastroesophageal reflux disease, despite its uncertain efficacy."3.78Domperidone: ventricular arrhythmia and sudden death (continued). ( , 2012)
" In the second case, QT interval prolongation occurred in a patient taking quetiapine and citalopram, and whose use of hydrocholorothiazide and history of chronic alcohol abuse likely contributed by rendering the patient hypokalemic."3.76Multifactorial QT interval prolongation. ( Baranchuk, A; Digby, G; Machaalany, J; Malik, P; Methot, M; Redfearn, D; Simpson, CS, 2010)
"To determine whether oral domperidone is associated with QT interval prolongation and ventricular arrhythmia and to identify factors that can influence these effects."3.74Effect of domperidone on QT interval in neonates. ( Djeddi, D; Kongolo, G; Lefaix, C; Léké, A; Mounard, J, 2008)
"Several cases of QT prolongation and ventricular tachyarrhythmia have been reported with domperidone, a gastrokinetic and antiemetic agent available worldwide but still under investigation in the United States."3.70Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. ( Cardinal, R; Daleau, P; Drolet, B; Rousseau, G; Turgeon, J, 2000)
"The risk of sudden cardiac death (SCD) can be increased with the use of drugs."3.01Drug-induced Sudden Death: A Scoping Review. ( Amaro-Hosey, K; Blanco-Silvente, L; Capellà, D; Castells, X; Loma-Osorio, P, 2023)
"To assess the steady-state pharmacokinetic and QT(c) effects of domperidone and ketoconazole, given alone and together."2.77Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study. ( Baisley, KJ; Boyce, MJ; Warrington, SJ, 2012)
"Domperidone is a proposed treatment of orthostatic hypotension (OH) in Parkinson's disease (PD)."2.55Domperidone for Hypotension in Parkinson's Disease: A Systematic Review. ( Bacchi, S; Chim, I; Kramer, P; Postuma, RB, 2017)
"Domperidone is a prokinetic agent widely prescribed in adults and children with gastrointestinal disorders."2.46Domperidone and long QT syndrome. ( Giorgi, G; Rossi, M, 2010)
"The risk of serious ventricular arrhythmias (SVA) in clinical practice in China has not been investigated."1.56Risk of Serious Ventricular Arrhythmia in Users of Gastrointestinal Medications: A Retrospective Cohort Study in China. ( Jiang, K; Liang, W; Qiu, H; Shu, M; Wu, K; Zhang, D; Zhang, Y, 2020)
"The phenomenon of sudden cardiac death is usually related to the worsening of existing heart conditions leading to ventricular arrhythmia (VA)."1.42A case of sudden cardiac death following Domperidone self-medication. ( De Leo, D; Fais, P; Gottardo, R; Laposata, C; Lockwood, R; Vermiglio, E, 2015)
"There have been reports of cardiac arrest in older patients associated with domperidone."1.27Continuous ECG monitoring of children with cancer receiving domperidone. ( Campbell, RW; Craft, AW; Hunter, AS; Nobbs, J; Pritchard-Jones, K; Ratcliffe, JM, 1986)
"Severe cardiac arrhythmias occurred in two patients."1.27Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidone. ( Hamer, J; Hunter, RW; Osborne, RJ; Slevin, ML, 1985)

Research

Studies (36)

TimeframeStudies, this research(%)All Research%
pre-19904 (11.11)18.7374
1990's0 (0.00)18.2507
2000's4 (11.11)29.6817
2010's24 (66.67)24.3611
2020's4 (11.11)2.80

Authors

AuthorsStudies
Amaro-Hosey, K1
Castells, X1
Blanco-Silvente, L1
Loma-Osorio, P1
Capellà, D1
Zhang, Y1
Shu, M1
Liang, W1
Jiang, K1
Zhang, D1
Qiu, H1
Wu, K1
Song, BG1
Lee, YC1
Min, YW1
Kim, K1
Lee, H1
Son, HJ1
Rhee, PL1
Ou, LB1
Moriello, C1
Douros, A1
Filion, KB1
Frommeyer, G2
Fischer, C2
Ellermann, C2
Dechering, DG2
Kochhäuser, S2
Lange, PS2
Wasmer, K1
Fehr, M2
Eckardt, L2
Grzeskowiak, LE2
Smithers, LG1
Smolina, K2
Morgan, S1
Mintzes, B2
Hanley, G1
Oberlander, T1
Bacchi, S1
Chim, I1
Kramer, P1
Postuma, RB1
Yüksel, K1
Tuğlular, I1
Fife, D2
Waller, J1
Kaplan, S1
Hu, P1
Phillips, S1
Oliveria, SA1
Richarz, U1
Amir, LH1
Caraballo, L2
Molina, G2
Weitz, D2
Piskulic, L2
Avila, A2
Marzi, M2
Chen, HL1
Hsiao, FY1
Buffery, PJ1
Strother, RM1
Fais, P1
Vermiglio, E1
Laposata, C1
Lockwood, R1
Gottardo, R1
De Leo, D1
Leelakanok, N1
Holcombe, A1
Schweizer, ML1
Hanley, GE1
Oberlander, TF1
Morgan, SG1
Forbes, N1
Cooray, M1
Al-Dabbagh, R1
Yuan, Y1
Tse, F1
Liu, LW1
Xenodemetropoulos, T1
Rochoy, M1
Auffret, M1
Béné, J1
Gautier, S1
Djeddi, D1
Kongolo, G1
Lefaix, C1
Mounard, J1
Léké, A1
Hennessy, S1
Leonard, CE1
Palumbo, CM1
Bilker, WB1
Newcomb, C1
Kimmel, SE1
Rossi, M1
Giorgi, G1
Digby, G1
Machaalany, J1
Malik, P1
Methot, M1
Simpson, CS1
Redfearn, D1
Baranchuk, A1
Johannes, CB1
Varas-Lorenzo, C1
McQuay, LJ1
Midkiff, KD1
Boyce, MJ1
Baisley, KJ1
Warrington, SJ1
Bozzo, P1
Koren, G1
Ito, S1
Drolet, B1
Rousseau, G1
Daleau, P1
Cardinal, R1
Turgeon, J1
Osborne, RJ2
Slevin, ML2
Hunter, RW2
Hamer, J2
Quinn, N1
Parkes, D1
Jackson, G1
Upward, J1
Ratcliffe, JM1
Nobbs, J1
Campbell, RW1
Hunter, AS1
Pritchard-Jones, K1
Craft, AW1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Randomized Clinical Trial: Use of Domperidone to Increase Milk Production in Mothers With Newborns Hospitalized in Neonatology[NCT03221855]Early Phase 130 participants (Actual)Interventional2013-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

9 reviews available for domperidone and Arrhythmias, Cardiac

ArticleYear
Drug-induced Sudden Death: A Scoping Review.
    Current drug safety, 2023, Volume: 18, Issue:3

    Topics: Antipsychotic Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Humans; Risk Factor

2023
Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies.
    British journal of clinical pharmacology, 2021, Volume: 87, Issue:10

    Topics: Antiemetics; Arrhythmias, Cardiac; Cross-Over Studies; Death, Sudden, Cardiac; Domperidone; Humans;

2021
Domperidone for Hypotension in Parkinson's Disease: A Systematic Review.
    Journal of Parkinson's disease, 2017, Volume: 7, Issue:4

    Topics: Animals; Arrhythmias, Cardiac; Databases, Bibliographic; Death, Sudden, Cardiac; Domperidone; Dopami

2017
Critical review of European Medicines Agency (EMA) assessment report and related literature on domperidone.
    International journal of clinical pharmacy, 2019, Volume: 41, Issue:2

    Topics: Antiemetics; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Humans; Metoclopramide; Risk

2019
[Proarrhythmic effects of domperidone in infants: a systematic review].
    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2014, Sep-16, Volume: 38, Issue:5

    Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Cisapride; Contraindications; Cytochrome P-450 CYP3A; Dom

2014
[Cardiac adverse effects of domperidone in adult patients: a systematic review].
    Revista medica de Chile, 2015, Volume: 143, Issue:1

    Topics: Adult; Antiemetics; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Female; Gastroesophag

2015
Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations.
    The New Zealand medical journal, 2015, Jun-12, Volume: 128, Issue:1416

    Topics: Antiemetics; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Death, Sudde

2015
Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis.
    Clinical drug investigation, 2016, Volume: 36, Issue:2

    Topics: Antiemetics; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Case-Control

2016
Domperidone and long QT syndrome.
    Current drug safety, 2010, Jul-02, Volume: 5, Issue:3

    Topics: Adult; Animals; Arrhythmias, Cardiac; Child; Death, Sudden, Cardiac; Domperidone; Dopamine Antagonis

2010

Trials

1 trial available for domperidone and Arrhythmias, Cardiac

ArticleYear
Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study.
    British journal of clinical pharmacology, 2012, Volume: 73, Issue:3

    Topics: 14-alpha Demethylase Inhibitors; Adolescent; Adult; Analysis of Variance; Area Under Curve; Arrhythm

2012

Other Studies

26 other studies available for domperidone and Arrhythmias, Cardiac

ArticleYear
Risk of Serious Ventricular Arrhythmia in Users of Gastrointestinal Medications: A Retrospective Cohort Study in China.
    Advances in therapy, 2020, Volume: 37, Issue:4

    Topics: Administration, Oral; Adult; Antiemetics; Arrhythmias, Cardiac; China; Databases, Factual; Domperido

2020
Risk of domperidone induced severe ventricular arrhythmia.
    Scientific reports, 2020, 07-22, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Aged; Antiemetics; Arrhythmias, Cardiac; Benzamides; Benzyl Compounds; Child; Chi

2020
Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents.
    Cardiovascular toxicology, 2018, Volume: 18, Issue:1

    Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Domperidone; Drug Interactions; Erythromycin; Fema

2018
Use of domperidone and risk of ventricular arrhythmia in the postpartum period: getting to the heart of the matter.
    Pharmacoepidemiology and drug safety, 2017, Volume: 26, Issue:7

    Topics: Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Female; Humans; Postpartum Period

2017
Response to "use of domperidone and risk of ventricular arrhythmia in the postpartum period: Getting to the heart of the matter".
    Pharmacoepidemiology and drug safety, 2017, Volume: 26, Issue:7

    Topics: Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Female; Humans; Postpartum Period

2017
Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia.
    Prescrire international, 2016, Volume: 25, Issue:175

    Topics: Antiemetics; Arrhythmias, Cardiac; Clinical Decision-Making; Death, Sudden, Cardiac; Domperidone; Do

2016
Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe.
    Clinical drug investigation, 2019, Volume: 39, Issue:11

    Topics: Adult; Antiemetics; Arrhythmias, Cardiac; Cardiac Conduction System Disease; Cross-Sectional Studies

2019
Pharmacological management of low milk supply with domperidone: separating fact from fiction.
    The Medical journal of Australia, 2014, Sep-01, Volume: 201, Issue:5

    Topics: Age Factors; Arrhythmias, Cardiac; Breast Feeding; Death, Sudden, Cardiac; Domperidone; Dopamine Ant

2014
Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study.
    Pharmacoepidemiology and drug safety, 2015, Volume: 24, Issue:8

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Case-Control Studies; Co

2015
A case of sudden cardiac death following Domperidone self-medication.
    Forensic science international, 2015, Volume: 254

    Topics: Alcoholism; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Female; Gastrointestinal Agen

2015
The association between domperidone and ventricular arrhythmia in the postpartum period.
    Pharmacoepidemiology and drug safety, 2016, Volume: 25, Issue:10

    Topics: Adult; Arrhythmias, Cardiac; British Columbia; Cohort Studies; Domperidone; Dopamine Antagonists; Fe

2016
Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a "Black Box" Warning: A Canadian Tertiary Care Center Study.
    Canadian journal of gastroenterology & hepatology, 2016, Volume: 2016

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperido

2016
[Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].
    Revue d'epidemiologie et de sante publique, 2017, Volume: 65, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Arrhythmias, Cardiac; Brugada Syndrome; Car

2017
Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and Domperidone.
    Cardiovascular toxicology, 2017, Volume: 17, Issue:4

    Topics: Animals; Antiemetics; Arrhythmias, Cardiac; Domperidone; Dose-Response Relationship, Drug; Female; O

2017
Domperidone and sudden death. Cardiac rhythm disorders: QT interval prolongation.
    Prescrire international, 2008, Volume: 17, Issue:94

    Topics: Antiemetics; Arrhythmias, Cardiac; Canada; Death, Sudden, Cardiac; Domperidone; Humans; Long QT Synd

2008
Effect of domperidone on QT interval in neonates.
    The Journal of pediatrics, 2008, Volume: 153, Issue:5

    Topics: Administration, Oral; Arrhythmias, Cardiac; Domperidone; Dopamine Antagonists; Drug-Related Side Eff

2008
Diagnostic codes for sudden cardiac death and ventricular arrhythmia functioned poorly to identify outpatient events in EPIC's General Practice Research Database.
    Pharmacoepidemiology and drug safety, 2008, Volume: 17, Issue:12

    Topics: Arrhythmias, Cardiac; Cisapride; Cohort Studies; Databases, Factual; Death, Sudden, Cardiac; Domperi

2008
Multifactorial QT interval prolongation.
    Cardiology journal, 2010, Volume: 17, Issue:2

    Topics: Alcoholism; Amiodarone; Antipsychotic Agents; Arrhythmias, Cardiac; Biomarkers; Citalopram; Cyclohex

2010
Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study.
    Pharmacoepidemiology and drug safety, 2010, Volume: 19, Issue:9

    Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Case-Contro

2010
Domperidone: ventricular arrhythmia and sudden death (continued).
    Prescrire international, 2012, Volume: 21, Issue:129

    Topics: Aged; Antipsychotic Agents; Arrhythmias, Cardiac; Death, Sudden; Domperidone; Female; Gastroesophage

2012
Health Canada advisory on domperidone should I avoid prescribing domperidone to women to increase milk production [corrected]?
    Canadian family physician Medecin de famille canadien, 2012, Volume: 58, Issue:9

    Topics: Arrhythmias, Cardiac; Canada; Death, Sudden, Cardiac; Domperidone; Female; Galactogogues; Humans; La

2012
Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders.
    Circulation, 2000, Oct-17, Volume: 102, Issue:16

    Topics: Action Potentials; Animals; Antiemetics; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cation Tr

2000
Cardiotoxicity of intravenous domperidone.
    Lancet (London, England), 1985, Aug-17, Volume: 2, Issue:8451

    Topics: Arrhythmias, Cardiac; Domperidone; Female; Humans; Infusions, Parenteral; Vomiting

1985
Cardiotoxicity of domperidone.
    Lancet (London, England), 1985, Sep-28, Volume: 2, Issue:8457

    Topics: Aged; Arrhythmias, Cardiac; Domperidone; Heart; Humans; Male

1985
Continuous ECG monitoring of children with cancer receiving domperidone.
    Pediatric hematology and oncology, 1986, Volume: 3, Issue:4

    Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Child

1986
Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidone.
    Human toxicology, 1985, Volume: 4, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Cisplat

1985